Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • terridiamond158 terridiamond158 Mar 6, 2013 11:44 AM Flag

    Leerink Raises CLDX to $18 A Day Before CLDX to Make Big Announcement. LINK

    Celldex Therapeutics (CLDX +2.3%) moves up after being initiated by Leerink Swann
    Seeking Alpha Market Currents
    · Wednesday, March 6, 11:11 AM ET
    Celldex Therapeutics (CLDX +2.3%) moves up after being initiated by Leerink Swann with an Outperform rating and a price target of $18 a share. Leerink cites the strength of the drug developer's portfolio, saying 6 wholly owned clinical-stage biologics assets make its breadth rare among small and mid-cap biotech companies. The coverage also comes just a day before the company is expected to announce plans for a late stage study of CDX-011, a treatment for metastatic breast cancer - which should be a key catalyst for the stock.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CLDX
27.80+0.66(+2.43%)May 22 4:00 PMEDT